Synthesis of RP 48497, an Impurity of Eszopiclone
1
Key Lab of New Drug Design and Discovery of Liaoning Province, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
2
Jinzhou Jiutai Pharmaceutical Co. Ltd, Jinzhou 121012, P.R. China
*
Author to whom correspondence should be addressed.
Molecules 2008, 13(8), 1817-1821; https://doi.org/10.3390/molecules13081817
Received: 5 June 2008 / Revised: 8 August 2008 / Accepted: 12 August 2008 / Published: 22 August 2008
RP 48497 is a photodegradation product of eszopiclone, a non-benzodiazepine sedative-hypnotic used in the treatment of insomnia. We report herein the first synthesis of RP 48497 via reduction, chlorination, and recyclization of 6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydropyrrolo[3,4-b]pyrazin-5-one (3), a key intermediate in the synthesis of eszopiclone. The structure of RP 48497 was confirmed by its 1H-NMR and MS data. The mechanism of the reduction step in the synthesis of RP 48497 was also studied and the key parameters were determined. These findings should be important for quality control purposes in the manufacture of eszopiclone.
View Full-Text
Keywords:
RP 48497; eszopiclone; quality control
▼
Show Figures
Figure 1
This is an open access article distributed under the Creative Commons Attribution License
MDPI and ACS Style
Sharov, Y.; Zhang, L.; Du, G.-J.; Ren, J.; Cheng, M.-S. Synthesis of RP 48497, an Impurity of Eszopiclone. Molecules 2008, 13, 1817-1821. https://doi.org/10.3390/molecules13081817
AMA Style
Sharov Y, Zhang L, Du G-J, Ren J, Cheng M-S. Synthesis of RP 48497, an Impurity of Eszopiclone. Molecules. 2008; 13(8):1817-1821. https://doi.org/10.3390/molecules13081817
Chicago/Turabian StyleSharov, Yu; Zhang, Lei; Du, Gui-Jie; Ren, Jian; Cheng, Mao-Sheng. 2008. "Synthesis of RP 48497, an Impurity of Eszopiclone" Molecules 13, no. 8: 1817-1821. https://doi.org/10.3390/molecules13081817
Find Other Styles
Search more from Scilit
